Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2015 Financial Results and Reaffirms 2016 Outlook

Go back to Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2015 Financial Results and Reaffirms 2016 Outlook

Emergent BioSolutions (EBS) Tops Q4 EPS by 8c

February 25, 2016 4:52 PM EST

Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.78, $0.08 better than the analyst estimate of $0.70. Revenue for the quarter came in at $168.1 million versus the consensus estimate of $168.07 million.

For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.

... More